VRXA Veraxa Biotech AG
Company Analysis
Latest News
🟢 Veraxa Biotech is trading 11% up today amid renewed biotech IPO appetite
Veraxa Biotech is trading 11.02% up now at $1.21, in line with supportive biotech-sector sentiment. - No company-specific headline was reported for October 9,...
🟢 Veraxa Biotech is trading 6.9% up amid a biotech-sector rally
Veraxa Biotech is trading 6.9% up at $1.17, with a biotech-sector rally potentially supporting shares. - No new company-specific announcement for October 9...
🔴 Veraxa Biotech is trading 5% down; no direct catalyst confirmed
Veraxa Biotech is trading 5% down at $1.14 on October 8, 2026, with biotech-sector weakness the most relevant context; no direct catalyst is confirmed. - The...
🔴 Veraxa Biotech is trading 5.8% down in after-hours trading
Veraxa Biotech is trading 5.8% lower at $1.13 in after-hours trading; no specific catalyst for the decline was reported. - It closed the October 7 regular...
🟢 Veraxa Biotech shares surge 10% after unveiling FDA-aligned preclinical testing strategy
Veraxa Biotech is trading 10.19% up at $1.19 on October 7, 2026, after announcing the implementation of FDA-aligned New Approach Methodologies across its...
Veraxa Rides an FDA Regulatory Wave With a Lab-Methods Announcement — But Can Press Releases Substitute for Revenue?
Shares of Veraxa Biotech shifted sharply higher on October 7, rising 8.3% to $1.17, bucking a weak biotech sector. The catalyst: a press release announcing the...
🟢 Veraxa Biotech is trading 10% up today with FDA-aligned preclinical methods a possible catalyst
Veraxa Biotech is trading at $1.17, up 9.72%; its announcement is a plausible catalyst. - On October 7, 2026, it said it is implementing FDA-aligned New...
🟢 Veraxa Biotech is trading 10% up in pre-market; catalyst remains unclear
Veraxa Biotech is trading 10.19% up in pre-market at $1.19 on October 7, 2026, compared with its October 6 close of $1.08; no confirmed company-specific...
🔴 Veraxa Biotech is trading 5% down today
Veraxa Biotech is trading 5.31% lower at $1.07, with no confirmed company-specific catalyst identified. - The company’s investor-relations page lists its...
🟢 Veraxa Biotech is trading 7.3% up in pre-market
Veraxa Biotech is trading 7.33% up in pre-market at $1.21, compared with its October 5 close of $1.13; no clear overnight catalyst was identified. - The...
🔴 Veraxa Biotech is trading 5.9% down as five-session slide extends
Veraxa Biotech is trading 5.89% down at $1.12 on October 2, 2026, as the immediate catalyst remains unclear. - The decline extends a five-session slide, with...
🟢 Veraxa Biotech is trading 5% up in pre-market
Veraxa Biotech is trading 5.04% higher at $1.25 in pre-market; available evidence does not establish a catalyst. - This compares with the October 1 close of...
🔴 Veraxa Biotech is trading 5% down; no clear catalyst identified
Veraxa Biotech is trading lower at $1.24, down 5.34%, on September 30, 2026, with no clear company-specific catalyst identified. - The event calendar lists a...
🔴 Veraxa Biotech is trading 5% down with no clear catalyst identified
Veraxa Biotech is trading 5.1% lower at $1.30 on September 29, 2026, with no clear company-specific catalyst identified. - Shares closed at $1.37 on September...
🟢 Veraxa Biotech is trading 6.38% up in pre-market amid broader biotech strength
Veraxa Biotech is trading 6.38% higher at $1.50 in pre-market following broader biotechnology strength; no company-specific catalyst was identified. - Shares...
🟢 Veraxa Biotech is trading 6.5% up in pre-market amid broader biotech momentum
Veraxa Biotech is trading 6.5% up in pre-market at $1.48, versus the September 23 close of $1.39, amid broader biotech momentum on September 24, 2026. - XBI...
🟢 Veraxa Biotech is trading 11.35% up in pre-market on biotech-sector strength
Veraxa Biotech is trading at $1.57, up 11.35%, with biotech-sector strength providing the strongest explanation. - No fresh company-specific announcement or...
🟢 Veraxa Biotech is trading 5.63% up in pre-market — no fresh catalyst identified
Veraxa Biotech is trading 5.63% up at $1.50 after rising from the September 21 close of $1.42; no fresh company-specific catalyst dated September 22, 2026 was...
🟢 Veraxa Biotech is trading 7.89% up in pre-market with no clear catalyst identified
Veraxa Biotech is trading 7.89% up at $1.64 in pre-market; no new company-specific announcement was identified for September 16, 2026, and the immediate reason...
🔴 Veraxa Biotech is trading 5.52% down today amid biotech-sector pressure after disappointing drug-trial news elsewhere
Veraxa Biotech is trading 5.52% down at $1.54, with biotechnology weakness and broad risk-off conditions the most likely immediate drivers. - No...